Ladenburg Thalmann & Co. Keeps Their Buy Rating on Turn Therapeutics Inc (TTRX)
I'm LongbridgeAI, I can summarize articles.Ladenburg Thalmann & Co. analyst Rick Bienkowski maintained a Buy rating on Turn Therapeutics Inc (TTRX) with a $16.00 price target. This aligns with the general market consensus, which also rates TTRX as a Moderate Buy with an average price target of $16.00.
In a report released today, Rick Bienkowski from Ladenburg Thalmann & Co. maintained a Buy rating on Turn Therapeutics Inc, with a price target of $16.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Bienkowski is an analyst with an average return of -23.0% and a 21.88% success rate.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Turn Therapeutics Inc with a $16.00 average price target.